Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
Regeneron inks $150M pact with gene writer Tessera
The companies will jointly develop and commercialize Tessera's TSRA-196, a near-clinic candidate for alpha-1 antitrypsin deficiency (AATD).
Zoey Becker
Dec 1, 2025 11:12am
Fierce Healthcare
CDC updates website to promote debunked vaccine-autism link
Nov 20, 2025 4:20pm
How a talk with RFK Jr. kicked off the FDA's gene therapy push
Nov 20, 2025 2:00pm
Genetic medicines biotech halves team
Nov 20, 2025 10:15am
Aspen adds $115M series C to grow cell therapy ambitions
Nov 20, 2025 7:02am
Tempest strikes all-stock deal for Factor’s CAR-T pipeline, CEO
Nov 19, 2025 12:22pm
